The mechanisms of the neurotropic action of bromantan
I. S. Morozov, G. S. Pukhova, N. A. Avdulov, S. A. Sergeeva, A. A. Spasov, I. N. Iezhitsa · 1999 · Eksp Klin Farmakol. 62(1):11–14
What does this source report?
Experimental work examined dopamine, serotonin, and noradrenergic responses. These are mechanistic observations, not evidence of human cognitive or sleep benefits.
- Population and setting
- Animal experiments and synaptosomal assays
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- Russian
- Title provenance
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
What are the limitations?
- Species, assays, and exposures differ from everyday human use.
- A neurotransmitter-related signal does not establish a clinical mechanism or long-term safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
PubMed record and English abstract checked.
Recorded source-check date: 2026-09-27. This date does not imply a completed systematic review.
Cite and trace this record
Original source: I. S. Morozov, G. S. Pukhova, N. A. Avdulov, S. A. Sergeeva, A. A. Spasov, I. N. Iezhitsa. The mechanisms of the neurotropic action of bromantan Eksp Klin Farmakol. 62(1):11–14 1999.
Molekul research summary: https://molekul.io/research/bromantane-1999-mechanisms. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry